Login
Toggle navigation
Videos
Categories
Trending
The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Riber appoints Philippe Ley as CEO and board member
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
A new venture capital firm focused on providing growth capital to the deep technology sector|WENDELL BROOKS,FOUNDER AND MANAGING PARTNER,Snowcloud Capital
00:10:00
Presentation Overview: Valuation Upside of BCI Minerals
00:10:00
Diamyd Medical develops therapies for type 1 diabetes|Anders EssenMoller,Chairman,Diamyd Medical
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
Ultra Lithium Reports Promising Drill Results and Eyes Strategic Partnerships
00:10:00
Adopting Open Data for Finance Could Boost Economic Growth|Kabir Kumar,Director,Flourish Ventures
00:10:00
The Critical Role of Energy: Insights from Black Hills Corporation's CEO |Linn Evans, CEO , Black Hills Corporation
00:10:00
Interview with Carlos and Takara: Founder & CEO of Novel Capital on Non-Dilutive Financing for Entrepreneurs
00:10:00
Inside Danieli's New Innovation Center
00:10:00
Darren Hazelwood Discusses Panther Metals' Dotted Lake Drilling Program in Ontario | Darren Hazelwood, CEO, Panther Metals Ltd.
00:10:00
Origin Reports Strong Financial Results and Outlines Strategic Vision for Leading the Energy Transition | Frank Calabria, CEO, Origin Energy Ltd .
00:10:00
Stephanie Sirota is a partner at RTW Investments, while Jensen Huang is the founder and CEO of NVIDIA, and a Stanford graduate.